SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ:…
Ski Jumping: suspension of Norwegian athletes is lifted for the offseason
Apr 01, 2025 - Following the conclusion of the 2024/25 season of…
NABR Applauds CITES Standing Committee’s Decision Not to Enact Trade Suspension on Cambodia’s Long-Tailed Macaques
WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- The National Association for Biomedical Research…
